Last update 08 May 2025

GNAI2 x EGF

Basic Info

Related Targets
GNAI2EGF

Related

1
Drugs associated with GNAI2 x EGF
US20220340526
Patent Mining
Target
EGF x GNAI2
Mechanism
GNAI2 inhibitors
Active Org.
The Georgia Tech Research Corp.The Georgia Tech Research Corp.
Originator Org.
The Georgia Tech Research Corp.The Georgia Tech Research Corp.
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with GNAI2 x EGF
Login to view more data
100 Translational Medicine associated with GNAI2 x EGF
Login to view more data
0 Patents (Medical) associated with GNAI2 x EGF
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free